Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of coexistent psoriasis and lupus erythematosus.
Varada S, Gottlieb AB, Merola JF, Saraiya AR, Tintle SJ. Varada S, et al. J Am Acad Dermatol. 2015 Feb;72(2):253-60. doi: 10.1016/j.jaad.2014.10.038. Epub 2014 Dec 6. J Am Acad Dermatol. 2015. PMID: 25486913
Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib.
Rothstein B, Joshipura D, Saraiya A, Abdat R, Ashkar H, Turkowski Y, Sheth V, Huang V, Au SC, Kachuk C, Dumont N, Gottlieb AB, Rosmarin D. Rothstein B, et al. Among authors: saraiya a. J Am Acad Dermatol. 2017 Jun;76(6):1054-1060.e1. doi: 10.1016/j.jaad.2017.02.049. Epub 2017 Apr 5. J Am Acad Dermatol. 2017. PMID: 28390737
Secukinumab in the treatment of moderate to severe hidradenitis suppurativa: Results of an open-label trial.
Casseres RG, Prussick L, Zancanaro P, Rothstein B, Joshipura D, Saraiya A, Turkowski Y, Au SC, Alomran A, Abdat R, Abudu M, Kachuk C, Dumont N, Gottlieb AB, Rosmarin D. Casseres RG, et al. Among authors: saraiya a. J Am Acad Dermatol. 2020 Jun;82(6):1524-1526. doi: 10.1016/j.jaad.2020.02.005. Epub 2020 Feb 7. J Am Acad Dermatol. 2020. PMID: 32044410 Clinical Trial. No abstract available.
Open-label, investigator-initiated, single-site exploratory trial evaluating secukinumab, an anti-interleukin-17A monoclonal antibody, for patients with moderate-to-severe hidradenitis suppurativa.
Prussick L, Rothstein B, Joshipura D, Saraiya A, Turkowski Y, Abdat R, Alomran A, Zancanaro P, Kachuk C, Dumont N, Gottlieb AB, Rosmarin D. Prussick L, et al. Among authors: saraiya a. Br J Dermatol. 2019 Sep;181(3):609-611. doi: 10.1111/bjd.17822. Epub 2019 May 12. Br J Dermatol. 2019. PMID: 30801662 Clinical Trial. No abstract available.
Magic of the Skin.
Saraiya A, Varada S. Saraiya A, et al. JAMA Dermatol. 2015 Jun;151(6):645. doi: 10.1001/jamadermatol.2014.5206. JAMA Dermatol. 2015. PMID: 25671410 No abstract available.
34 results